MedTrace Logo

Characterization and Epigenetics of Post-Partum Preeclampsia

NCT02935556 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2024-03-20

No results posted yet for this study

Summary

This study will recruit women with post partum pre-eclampsia and match them to controls without postpartum pre-eclampsia to identify an epigenetic signature that is specific to women with post partum pre-eclampsia to help characterize the underlying pathophysiology of post partum pre-eclampsia.

Conditions

  • Post Partum Pre-eclampsia

Interventions

OTHER

no intervention

database and epigenetic study

Sponsors & Collaborators

  • New York University

    collaborator OTHER

  • Society for Obstetric Anesthesia and Perinatology

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Marie-Louise Meng, MD · Columbia University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2022-03-09
Completion
2022-03-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02935556 on ClinicalTrials.gov